Real-time quantitative detection of Vampirovibrio chlorellavorus, an obligate bacterial pathogen of Chlorella sorokiniana
Not provided.
SEARCH · Search NASA
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Not provided.
This study aimed to investigate the antibiofouling activity of 3-(trimethoxysilyl)-propyl, alkyldimethylammonium chloride-based (SilQUAT)-treated glass fiber-reinforced polyester (GFRP) composite panels in model cooling tower system. All surface characterization analyses were performed by using FTIR and XPS and showed that surface chemical composition peaks confirmed the successful coating of compound. The antibiofilm efficacy of the SilQUAT-treated GFRP panels was evaluated with culture, ATP measurement and live/dead fluorescence staining, for 6 months. To mimic mechanical interventions, the durability and residual self-sanitizing activity of the treated GFRP panels was tested by modifying the EPA # 01-1A protocol, after abrasion. At the end of the 6-month period, the antibacterial effect was 95% and 99.90% for abraded and non-abraded materials, respectively. The current study provides an alternative application to prevent biofilm at source by modification and imparting antibacterial properties to the material. Prevention of biofilm at its source is an important approach by providing indirect benefits such as the reduction in corrosion and secondary environmental pollution caused by the use of excess biocides, and consequently, the reduction in cost and the risk of harm to the public/environment will also be of interest.
Not Available
Highlights: • HL-217 is a new synthetic topical anti-angiogenic agent. • HL-217 attenuated subretinal neovascularization in Vldlr{sup −/−} mice. • HL-217 blocked the binding of PDGF-BB to PDGFRβ. - Abstract: HL-217 is a new synthetic angiogenesis inhibitor. Platelet derived growth factor (PDGF) is a vasoactive factor and has been implicated in proliferative retinopathies. In this study, we examined the mechanism of action and efficacy of topical application of HL-217 on subretinal neovascularization in very low-density lipoprotein receptor knockout (Vldlr{sup −/−}) mice. In three-week-old male Vldlr{sup −/−} mice, HL-217 (1.5 or 3 mg/ml) was administered twice per day for 4 weeks by topical eye drop instillation. Neovascular areas were then measured. We used a protein array to evaluate the expression levels of angiogenic factors. The inhibitory effect of HL-217 on the PDGF-BB/PDGFRβ interaction was evaluated in vitro. The neovascular area in the Vldlr{sup −/−} mice was significantly reduced by HL-217. Additionally, HL-217 decreased the expression levels of PDGF-BB protein and VEGF mRNA. Moreover, HL-217 dose-dependently inhibited the PDGF-BB/PDGFRβ interaction (IC{sub 50} = 38.9 ± 0.7 μM). These results suggest that HL-217 is a potent inhibitor of PDGF-BB. HL-217, when applied topically, is an effective inhibitor of subretinal neovascularization due to its ability to inhibit the pro-angiogenic effects of PDGF-BB.
Explore the source record for details and available documents.
Not Available
Not Available
Organizations such as ASHRAE and the Centers for Disease Control and Prevention (CDC) have proposed guidelines for controlling infectious aerosols in buildings, which can be met through measures such as modified operation of the heating, ventilation, and air-conditioning (HVAC) system or incorporating air-cleaning technologies. However, more research is needed to understand the trade-offs between health, energy, and comfort aspects when designing measures for these guidelines. To address this gap, this paper presents an analysis using new models for air-cleaning technologies, including in-duct and in-room germicidal ultraviolet (GUV) systems and portable air cleaners (PACs). These models are incorporated into an existing prototypical office building model and six measures are designed to meet ASHRAE Standard 241 and CDC clean air targets: MERV 13 HVAC filtration, maximum outdoor air supplied to the building, PACs, and in-duct, upper-room, and whole-room GUV. The measures are simulated for an office building in a cool and humid climate compared against a baseline simulation using MERV 8 filtration. The results show that all measures, except for the maximum outdoor air case, can meet the ASHRAE 241 standard without significant impacts on energy or comfort. The HVAC system measures were not able to meet the CDC target with the default system sizing and lead to significant energy increases, while the in-room measures were able to meet the CDC target with small impacts on energy consumption. Finally, this paper consolidates the simulation findings and provides practical guidance for building operators to meet clean air targets while limiting energy and comfort impacts.
Not Available
Not Available
Not Available
Not Available
Not Available